Dr. Martens PLC

Director's Dealing • Sep 26, 2024

National Storage Mechanism | Additional information

RNS Number : 8571F

Dr. Martens PLC

26 September 2024

Dr. Martens plc 

Notification of transaction by Person Closely Associated with a PDMR

Dr. Martens plc (the ‘Company’) announces that on 26 September 2024 the following transaction in the Company’s ordinary shares was undertaken by a person closely associated with a director / person discharging managerial responsibility (‘PDMR’). 

The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1.

Details of PDMR / person closely associated with them 

a)

Name

Katie Wilson

2.

Reasons for the notification

a)

Position / status

Person Closely Associated with Giles Wilson, 

Chief Financial Officer and PDMR

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Dr. Martens plc

b)

Legal Entity Identifier code

213800QPT8YM6NQZPH28

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of GBP 0.01 each

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Purchase of Ordinary Shares

c) 

Price(s) and volume(s)

Price(s)	Volume(s)
£0.554	30,000

d)

Aggregated information

Aggregated volume

Price

N/A – single transaction

e)

Date of the transaction

26 September 2024

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUNVURSBUKUAR